IntraMed - Artículos - Asma Bronquial
Conceptos Actuales e Implicancias Económicas | 09 JUL 01
Asma Bronquial
Los conocimientos actuales indican que en el desarrollo de la atopía participan distintos aspectos que permiten sostener que se trata de una enfermedad sistémica con manifestaciones clínicas locales.
Autor: Dres. César Martín Bózzola y Hugo E. Neffen Fuente: Archivos de Alergia e Inmunología Clínica Archivos de Alergia e Inmunología Clínica
Referencias

1. Martinez FD, Stern DA, Wright AL, Holberg CJ, Taussig LM, Halonen M. Association of interleukin-2 and interferon-gama production gy blood mononuclear cells in infancy with parental allergy skin tests and with subsequent development of atopy. J Allergy Clin Immunol 1995; 96:652-660.

2. Denburg JA, Inman MD, Leber B, Sehmi R, O'Byrne PM. The role of the bone marrow in allergy and asthma. Allergy 1996; 51:141-148.

3. Egan RW, Umland SP, Cuss FM, Chapman RW. Biology of interleukin-5 and its relevance to allergic disease. Allergy 1996; 51:71-81.

4. Ohnishi M, Ruhno J, Dolovich J, Denburg JA. Allergic rhinitis nasal mucosal conditioned medium stimulates growth and differentiation of basophil/mast cell and eosinophil progenitors from atopic blood. J Allergy Clin Immunol 1988; 81:1149-1154.

5. Wood LJ, Inman MD, Watson RM, Foley R, Denburg JA, O'Byrne PM. Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med 1998; 157:99-105.

6. Agosti JM, Sprenger JD, Lum LG y col. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation. N Engl J Med. 1988; 1623-1628.
7. Wood LJ, Sehmi R, Gauvreau GM y col. An inhaled corticosteroid, budesonide, reduces baseline but not allergen-induced increases in bone marrow inflammatory cell progenitors in asthmatic subjects. Am J Respir Crit Care Med 1999; 159:1457-1463.

8. Strachan DP. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000 Aug; 55 Suppl 1:S2-10.

9. Strachan DP. Hay fever, higiene, and household size. BMJ 1989; 299:1259-1260.

10. Renzi PM, Turgeon JP, Yang JP, Drblik SP, Marcotte JE, Pedneault L y col. Cellular immunity is activated and a TH-2 reponse is associated with early wheezing in infants after bronchiolitis. J Pediatr 1997; 130:584-593.

11. Pershagen G. Can immunization affect the development of allergy? Pediatr Allergy Immunol 2000; 11 Suppl 13:26-8.

12. Yilmaz M, Bingol G, Altintas D, Kendirli SG. Correlation between atopic diseases and tuberculin responses. Allergy 2000 Jul; 55(7):664-7.

13. Von Mutius E, Braun-Fahrlander C, Schierl R, Riedler J, Ehlermann S, Maisch S, Waser M, Nowak D. Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy. 2000; 30:1230-1234.

14. Von Ehrenstein OS, Von Mutius E, Illi S, Baumann L, Bohm O and Von Kries R. Reduced risk of hay fever and asthma among children of farmers. Clin Exp Allergy. 2000; 30:187-193.

15. Galimany JR, Samaniego A, Daguerre MF, Vinuesa MA, Mindel E. Prevalencia de asma bronquial en la comunidad Toba de la ciudad de Rosario". Arch Alergia Inmunol Clin 2001; 32:11-15.

16. López A. Un remedio contra la pobreza. Diario La Nación 1 de abril 2001. Sección 2 p·g 3.

17. Fineman SM. Practice parameters: background and usefulness. Ann Allergy Asthma Immunol 2001; 86:5-10. 18. Villar BM. Cumplimiento de las estrategias en asma. Arch Alergia Inmunol Clin 2001; 32:5-10.

19. Li JT, Seeler RD, Offord KP, Patel AM, Dupras DM. Consultation for asthma: results of a generalist survey. Ann Allergy Asthma Immunol 1999; 83:203-206.

20. Ministerio de Economía. Proceso de transparencia en el Mercado de Medicamentos. http://www.mecon.gov.ar/index/medicamentos/intro.htm

21. Drazen JM. Genetics and its impact on asthma. 57th Annual Meeting, American Academy of Allergy, Asthma and Immunology. New Orleans 16-21 de marzo 2001.

22. Borish LC. Nelson H, Lanz M, Claussen L, Whitmore J, Agosti J, Garrison L. Recombinant human interukin 4 receptor in moderate atopic asthma: A randomised double-blind, placebo.controlled pilot study. Am J Respir Crit Care Med 1999; 160:1816-1823.

23. Fahy JV, Fleming HE, Wong HH y col. The effect of an anti-IgE monoclonal antibody on the early- and late.phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997; 155:1828-1834.

Comentarios

Usted debe estar registrado para expresar su opinión. Si ya es usuario de IntraMed o desea registrase como nuevo usuario, ingrese aquí
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2014